Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2<sup>+</sup> breast cancer: TBCRC049 phase 2 study results.

Nature cancer·2026
Same author

Bayesian Nonparametric Common Atoms Regression for Generating Synthetic Controls in Clinical Trials.

Journal of the American Statistical Association·2026
Same author

A Genomically Tailored Multiagent Precision Medicine Clinical Trial for Adults with Recurrent Glioblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy: A Preliminary Analysis of a Randomized Clinical Trial.

JAMA oncology·2025
Same author

Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial.

Nature communications·2025
Same author

Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy.

Neuro-oncology·2025
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Apr 15, 2026

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
05:45

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Published on: January 19, 2024

3.1K

High-grade gliomas.

John F de Groot

    Continuum (Minneapolis, Minn.)
    |April 4, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Standard treatments for high-grade gliomas are evolving with chemotherapy showing improved survival. Molecular markers are crucial for guiding treatment decisions in these challenging primary brain tumors.

    More Related Videos

    Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
    09:21

    Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

    Published on: March 20, 2026

    66
    Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
    10:58

    Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

    Published on: February 22, 2015

    13.6K

    Related Experiment Videos

    Last Updated: Apr 15, 2026

    Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
    05:45

    Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

    Published on: January 19, 2024

    3.1K
    Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
    09:21

    Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

    Published on: March 20, 2026

    66
    Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
    10:58

    Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

    Published on: February 22, 2015

    13.6K

    Area of Science:

    • Neuro-oncology
    • Cancer Therapeutics
    • Molecular Pathology

    Background:

    • High-grade gliomas are aggressive primary brain tumors with challenging treatment paradigms.
    • Current management relies on surgery and radiation, often with limited long-term success.

    Purpose of the Study:

    • To review standard treatments for high-grade gliomas.
    • To discuss emerging therapeutic advances and molecularly guided strategies.

    Main Methods:

    • Literature review of standard and novel therapies for high-grade gliomas.
    • Analysis of the role of molecular markers in diagnosis and treatment selection.

    Main Results:

    • Chemotherapy demonstrates improved overall survival in glioblastomas and anaplastic oligodendrogliomas.
    • Molecular markers are increasingly important for prognostic assessment and treatment guidance.
    • Despite advances, high-grade gliomas often exhibit disease progression, necessitating novel therapeutic development.

    Conclusions:

    • Managing high-grade gliomas is complex but rewarding, with rapid technological advancements.
    • Molecular data aids in classifying gliomas and understanding disease drivers.
    • Investigator collaboration is vital for validating biomarkers and personalizing therapies.